| Bioactivity | CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2/PIM1-IN-1 is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, vascular disorders, pathogenic infections and certain immunological disorders[1]. |
| Invitro | CK2/PIM1-IN-1 a PIM kinases and CK2 inhibitor extracted from patent WO2010148351A1, Compound Example 64[1]. |
| Name | CK2/PIM1-IN-1 |
| CAS | 292640-28-9 |
| Formula | C15H9NO4S2 |
| Molar Mass | 331.37 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mustapha Haddach, et al. Rhodanines and related heterocycles as kinase inhibitors. WO2010148351A1. |
CK2/PIM1-IN-1
CAS: 292640-28-9 F: C15H9NO4S2 W: 331.37
CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.